Zobrazeno 1 - 10
of 50
pro vyhledávání: '"CPE, Cytopathic effect"'
Autor:
Henry W. Lim, Qing-Sheng Mi, Carla D. Pretto-Kernahan, Jonathan Z. Sexton, Shanthi Narla, Iltefat H. Hamzavi, Carmen Mirabelli, David M. Ozog, Robert J. Tibbetts
Publikováno v:
International Journal of Infectious Diseases, Vol 100, Iss, Pp 224-229 (2020)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Highlights • Ultraviolet C at a dose of 1.5 J/cm2 to both sides is effective on some models of N95 s. • Straps may require additional disinfection to decontaminate properly. • SARS-CoV-2 decontamination does not apply to all hospital respirator
Autor:
Wen Li, Hiroshi Kurihara, Chang Yan, Zhuo Luo, Rong-Rong He, Yi-Fang Li, Robert Dallmann, Xue Li
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 10, Iss 3, Pp 383-398 (2020)
Acta Pharmaceutica Sinica B, Vol 10, Iss 3, Pp 383-398 (2020)
Herpes simplex virus type 1 (HSV-1), a neurotropic herpes virus, is able to establish a lifelong latent infection in the human host. Following primary replication in mucosal epithelial cells, the virus can enter sensory neurons innervating peripheral
Autor:
Branislav Kovacech, Lubica Fialova, Peter Filipcik, Rostislav Skrabana, Monika Zilkova, Natalia Paulenka-Ivanovova, Andrej Kovac, Denisa Palova, Gabriela Paulikova Rolkova, Katarina Tomkova, Natalia Turic Csokova, Karina Markova, Michaela Skrabanova, Kristina Sinska, Neha Basheer, Petra Majerova, Jozef Hanes, Vojtech Parrak, Michal Prcina, Ondrej Cehlar, Martin Cente, Juraj Piestansky, Michal Fresser, Michal Novak, Monika Slavikova, Kristina Borsova, Viktoria Cabanova, Bronislava Brejova, Tomas Vinař, Jozef Nosek, Boris Klempa, Ludek Eyer, Vaclav Hönig, Martin Palus, Daniel Ruzek, Tereza Vyhlidalova, Petra Strakova, Blanka Mrazkova, Dagmar Zudova, Gizela Koubkova, Vendula Novosadova, Jan Prochazka, Radislav Sedlacek, Norbert Zilka, Eva Kontsekova
Publikováno v:
EBioMedicine, Vol 76, Iss, Pp 103818-(2022)
EBioMedicine
eBioMedicine
EBioMedicine
eBioMedicine
Summary: Background: The emergence of new SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta) that harbor mutations in the viral S protein raised concern about activity of current vaccines and therapeutic
Autor:
Weibo Wen, Hong-Mei Li, Qinhai Ma, Rong-Tao Li, Xueshan Xia, Yue Fang, Shu-Wei Dong, Zhili Shen, Peifang Xie, Jincun Zhao, Yulan Shao, Zifeng Yang
Publikováno v:
Phytomedicine
Background Qingwenjiere Mixture (QJM) is a traditional Chinese medicine (TCM) that has been shown to have remarkable clinical efficacy against COVID-19. However, little is known about the antiviral and anti-inflammatory activities of QJM against a wi
Autor:
Feihu Yan, Ying Guo, Logan Banadyga, Shihua He, Wenjun Zhu, Guo Jiamei, Xiangguo Qiu, Qing Chen, Tang Ke, Xiaoyu Zhang
Publikováno v:
Antiviral Research
Lassa virus (LASV) causes Lassa hemorrhagic fever in humans and poses a significant threat to public health in West Africa. Current therapeutic treatments for Lassa fever are limited, making the development of novel countermeasures an urgent priority
Autor:
Rick Matos, Divya Mirchandani, Scott C. Weaver, Diana Fernández, Jordi B. Torrelles, Varun Dwivedi, Jennifer Delgado, Nathen E. Bopp, Kenneth S. Plante, Vinay Shivanna, Patricia V. Aguilar, Jun Gyu Park, Luis Martinez-Sobrido, Jessica A. Plante, Paula Pino Tamayo, Robert A. Newman, K. Jagannadha Sastry
Publikováno v:
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy, Vol 138, Iss, Pp 111457-(2021)
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2021, 138, pp.111457. ⟨10.1016/j.biopha.2021.111457⟩
Biomedicine & Pharmacotherapy, Vol 138, Iss, Pp 111457-(2021)
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2021, 138, pp.111457. ⟨10.1016/j.biopha.2021.111457⟩
International audience; With continued expansion of the coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome 2 (SARS-CoV-2), both antiviral drugs as well as effective vaccines are desperately needed to treat patients a
Autor:
Ronald Gstir, Cornelia Lass-Flörl, Doris Wilflingseder, Lukas A. Huber, Giulia Bertacchi, Christina Witting, Rosa Bellmann-Weiler, Asma Noureen, Viktoria Zaderer, Jonathan Vosper, Wilfried Posch, Günther K. Bonn, Przemyslaw A. Filipek
Publikováno v:
Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
BACKGROUND: Excessive inflammation triggered by a hitherto undescribed mechanism is a hallmark of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and is associated with enhanced pathogenicity and mortality. OBJECTIVE: Compleme
Autor:
Wenshu Zheng, Jay K. Kolls, Prem P. Chapagain, Tony Y. Hu, Gregory J. Bix, Brandon J. Beddingfield, Chad J. Roy, Naoki Iwanaga
Publikováno v:
JACC: Basic to Translational Science
bioRxiv
article-version (status) pre
article-version (number) 1
bioRxiv
article-version (status) pre
article-version (number) 1
Many efforts to design and screen therapeutics for the current severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic have focused on inhibiting viral host cell entry by disrupting ACE2 binding with the SARS-CoV-2 spike protein. This wor
Autor:
Michael B. Steele, James M Bogenberger, Oumar Barro, Mitesh J. Borad, Nathan Jenks, Mansi Arora, Bolni Marius Nagalo, Yumei Zhou, Lewis R. Roberts, Camilo Breton, Alexander T. Baker, Stephen J. Russell, Kah Whye Peng, Dan G. Duda
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 546-555 (2020)
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 546-555 (2020)
Recombinant vesicular stomatitis virus (VSV)-fusion and hemagglutinin (FH) was developed by substituting the promiscuous VSV-G glycoprotein (G) gene in the backbone of VSV with genes encoding for the measles virus envelope proteins F and H. Hybrid VS
Autor:
Min Hui, Haiming Jiang, Zifeng Yang, Xiaobo Li, Zhoulang Wang, Jun Dai, Runfeng Li, Li Fu, Wenbo Huang, Jicheng Huang, Yongxia Shi, Qinhai Ma, Bin Liu, Kui Zheng, Yuqi Xie, Chufang Li, Weiqi Pan
Publikováno v:
Phytomedicine
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has extensively and rapidly spread in the world, causing an outbreak of acute infectious pneumonia. However, no specific antiviral drugs or vaccines can be used. Phillyrin (KD-1)